Global E Prescribing Market Size, Share, and Growth & Trends Analysis By Component: Software, Services; By Delivery Mode: Web/cloud-based, On-premises; By Substances: Controlled substances, Non-controlled substances; By Usage: Handheld, Computer-based devices; By Specialties: Oncology, Sports medicine, Neurology, Cardiology, Other specialties; By End Use: Hospital, Office-based physicians, Pharmacy, Other end-users; By Region (North America, Asia Pacific, Europe, Middle East & Africa, South America; Regional Outlook, Growth Potential and Segments Forecast 2024-2031

Loading...

Summary of Report:

The Global E Prescribing Market size was USD 3.20 billion in 2023 and is projected to reach USD 18.59 billion by 2031, with a CAGR of 24.7% during the forecast period. 

Price

Original price was: $3,999.00.Current price is: $2,999.00.
Original price was: $4,999.00.Current price is: $3,999.00.
Original price was: $9,999.00.Current price is: $8,999.00.

Do You have any Budget constraints?
Simply Ask our Sales Team About it.

Loading...

Description

The Global E Prescribing Market size was USD 3.20 billion in 2023 and is projected to reach USD 18.59 billion by 2031, with a CAGR of 24.7% during the forecast period. 

Global E Prescribing Market: Key Takeaways

  • Market Growth and Adoption:

The Global E-Prescribing Market is experiencing robust growth driven by increasing adoption of digital healthcare solutions and regulatory push for electronic health records. E-prescribing enhances accuracy and efficiency in prescription management, reducing medication errors and improving patient safety. The market is expected to expand due to technological advancements, rising healthcare IT investments, and growing demand for streamlined healthcare processes.

  • Regulatory Support and Standards:

Governments worldwide are supporting e-prescribing through regulations and incentives. Initiatives like the U.S. Medicare and Medicaid EHR Incentive Programs and the European Union’s eHealth Action Plan are encouraging healthcare providers to adopt e-prescribing systems. Compliance with standards such as the National Council for Prescription Drug Programs (NCPDP) SCRIPT standard is crucial for market players to ensure interoperability and data security.

  • Integration with Electronic Health Records (EHR):

Integration of e-prescribing systems with Electronic Health Records (EHR) is a key trend enhancing the market’s growth. This integration enables seamless data exchange between healthcare providers, pharmacists, and patients, leading to improved prescription accuracy and better patient outcomes. The synergy between e-prescribing and EHR systems also facilitates comprehensive patient care and efficient management of medical records.

  • Challenges and Opportunities:

Despite its growth, the e-prescribing market faces challenges such as data security concerns, system integration issues, and resistance from some healthcare professionals. However, these challenges present opportunities for innovation and improvement. Solutions like enhanced cybersecurity measures, user-friendly interfaces, and robust training programs can address these issues, fostering greater adoption and integration of e-prescribing systems in healthcare settings. 

Global E Prescribing Market: Overview

The global e-prescribing market is experiencing robust growth driven by technological advancements, regulatory support, and widespread adoption across healthcare settings. North America leads the market due to high electronic health records (EHR) adoption and supportive legislation, while the Asia Pacific region is also expanding rapidly, fueled by increased healthcare spending and technological innovations. Key technological trends include enhanced EHR integration, which provides real-time access to patient medication histories and clinical decision support tools, and the use of artificial intelligence (AI) to identify drug interactions, allergies, and dosage errors.

Mobile health (mHealth) applications are revolutionizing prescription management by allowing healthcare providers to handle prescriptions remotely, thus improving workflow efficiency and patient care coordination. Regulatory initiatives like the Medicare Electronic Prescribing Incentive Program in the U.S. and Electronic Prescription Services in Europe are promoting e-prescribing adoption by standardizing practices and enhancing patient safety. Additionally, regulations such as the SUPPORT for Patients and Communities Act are driving electronic prescribing for controlled substances.

Major companies like NextGen Healthcare, eClinicalWorks, Oracle (Cerner Corporation), and Allscripts Healthcare Solutions are leading the market with innovative solutions. However, challenges such as high implementation costs, workflow disruptions, and the need for skilled personnel persist. Despite these obstacles, the market’s trajectory remains positive, underscoring the ongoing advancements and increasing integration of e-prescribing systems in healthcare practices globally.

Global E Prescribing Market: Growth Drivers

  • Technological Advancements

The growth of the e-prescribing market is significantly driven by technological advancements. Modern e-prescribing systems offer features such as integrated decision support, drug interaction checks, and real-time access to patient information. These innovations enhance prescription accuracy and efficiency, reducing the risk of errors and improving patient safety. 

  • Government Initiatives and Regulations

Government initiatives and regulations promoting digital health solutions are crucial drivers for the e-prescribing market. Policies such as the 21st Century Cures Act in the U.S. mandate the use of e-prescribing for controlled substances, encouraging wider adoption among healthcare providers. These regulations aim to streamline prescription processes and enhance patient care, contributing to market growth.

  • Increasing Incidence of Chronic Diseases

The rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions is another significant growth driver. E-prescribing systems enable better management of chronic conditions by ensuring timely and accurate medication dispensation. With the growing number of patients requiring continuous medication management, e-prescribing solutions are increasingly adopted to improve treatment adherence and patient outcomes.

Global E Prescribing Market: Restraining Factors

  • Integration and Interoperability Issues

One of the primary restraints in the e-prescribing market is integration and interoperability challenges. E-prescribing systems often face difficulties in integrating with existing electronic health records (EHR) and pharmacy management systems. This lack of seamless data exchange can lead to inefficiencies and errors in prescription processes. Ensuring interoperability between different systems remains a significant challenge that can hinder market growth.

Global E Prescribing Market:  Opportunity Factors 

  • Expansion in Emerging Markets

Emerging markets present substantial growth opportunities for the e-prescribing industry. With increasing investments in healthcare infrastructure and digital health technologies, countries like India, China, and Brazil are rapidly adopting e-prescribing solutions. The expansion into these markets offers significant potential for revenue growth as healthcare systems modernize and digitalize.

  • Advancements in Mobile Health Applications

The development of mobile health (mHealth) applications is opening new avenues for e-prescribing solutions. Mobile apps that support prescription management, refill requests, and medication adherence are gaining popularity. These advancements enhance patient engagement and convenience, creating new opportunities for e-prescribing providers to expand their offerings and reach.

  • Focus on Patient Safety and Error Reduction

Increasing emphasis on patient safety and the reduction of medication errors presents opportunities for e-prescribing solutions. Systems equipped with advanced features such as drug interaction alerts and automated dosage recommendations contribute to safer prescribing practices. As healthcare systems prioritize error reduction and patient safety, the demand for sophisticated e-prescribing solutions is expected to rise.

Global E Prescribing Market: Challenges

  • Data Security and Privacy Concerns

Data security and privacy concerns are significant challenges in the e-prescribing market. The handling of sensitive patient information through digital platforms raises concerns about data breaches and unauthorized access. Ensuring robust security measures and compliance with data protection regulations, such as HIPAA in the U.S., is crucial to maintaining trust and ensuring the safe use of e-prescribing systems.

Global E Prescribing Market: Segment Insights

  • By Component:

The global e-prescribing market is segmented into software and services. Software solutions dominate this market, encompassing e-prescribing systems that enable healthcare providers to electronically send prescriptions to pharmacies, enhancing efficiency and reducing medication errors. These systems often include features such as drug interaction checks, formulary management, and decision support tools. Services in the e-prescribing market include implementation, training, and support services, which are crucial for integrating and maintaining e-prescribing systems within healthcare settings. The growing complexity of regulatory requirements and technological advancements drives the demand for both software and services, as healthcare providers seek comprehensive solutions to optimize prescribing practices and improve patient outcomes.

  • By Delivery Mode:

E-prescribing systems are delivered through web/cloud-based and on-premises models. Cloud-based solutions are increasingly popular due to their scalability, accessibility, and lower upfront costs. They allow for real-time updates, remote access, and reduced IT maintenance requirements. On-premises systems, while involving higher initial costs and maintenance, offer greater control and customization options, which some healthcare organizations prefer. The shift towards cloud-based solutions is driven by the need for more flexible, scalable, and cost-effective solutions, but on-premises systems remain relevant for organizations with specific regulatory or operational needs.

  • By Substances:

The e-prescribing market is also divided by substances into controlled and non-controlled substances. Controlled substances require more stringent regulatory oversight and secure prescription processes due to their potential for abuse. E-prescribing systems that handle controlled substances need robust security features and compliance with regulations such as the DEA’s e-prescribing rules. Non-controlled substances are more commonly prescribed and involve less stringent regulatory requirements. However, the need for e-prescribing solutions that can manage both types of substances is crucial for ensuring comprehensive prescribing practices and compliance across various healthcare settings.

  • By Usage:

In terms of usage, e-prescribing systems are categorized into handheld and computer-based devices. Handheld devices offer portability and convenience for healthcare providers, allowing them to write and transmit prescriptions from various locations within a clinical setting. Computer-based devices, including desktop and laptop systems, are commonly used in healthcare facilities for their larger screens and integration with other clinical software. The choice between handheld and computer-based devices depends on the provider’s workflow, the complexity of the prescriptions, and the need for mobility versus a more robust system.

  • By Specialties:

The e-prescribing market is further segmented by specialties such as oncology, sports medicine, neurology, cardiology, and other specialties. Specialized e-prescribing solutions cater to the unique needs of each medical field, such as oncology’s complex medication regimens or cardiology’s need for specific drug interactions. Each specialty benefits from tailored e-prescribing features that address their particular requirements, such as drug databases specific to cancer treatments or heart disease management. This segmentation ensures that e-prescribing systems can support a wide range of medical practices, improving efficiency and accuracy in prescribing for diverse patient populations.

  • By End Use:

The end-use segment includes hospitals, office-based physicians, pharmacies, and other end-users. Hospitals often require comprehensive e-prescribing solutions integrated with electronic health records (EHRs) for efficient medication management across various departments. Office-based physicians utilize e-prescribing to streamline patient care and enhance prescription accuracy. Pharmacies use e-prescribing systems to receive and process electronic prescriptions efficiently. Other end-users may include long-term care facilities and telemedicine providers. Each end-user category has specific needs for e-prescribing systems, influencing the market’s growth and adoption patterns.

  • By Region:

Geographically, the e-prescribing market spans North America, Asia Pacific, Europe, the Middle East & Africa, and South America. North America leads the market due to advanced healthcare infrastructure, regulatory support, and high adoption rates. Europe follows, driven by regulatory initiatives and technological advancements. Asia Pacific is experiencing rapid growth due to increasing healthcare investments and digitalization. The Middle East & Africa are expanding their e-prescribing capabilities with improving healthcare systems and infrastructure. South America is also showing growth potential as digital healthcare solutions gain traction across the region. Each region’s market dynamics are influenced by local regulations, technological advancements, and healthcare needs.

Global E Prescribing Market: Segmentation

  • Based on Component: The market is segmented into Solution & Services.
  • Based on Delivery Mode: The market is segmented into Web/cloud-based, On-premises
  • Based on Substances: The market is segmented into Controlled substances, Non-controlled substances.
  • Based on Usage: The market is segmented into Handheld, Computer-based devices.
  • Based on Specialties: The market is segmented into Oncology, Sports medicine, Neurology, Cardiology, Other specialties.
  • Based on End Use: The market is segmented into Hospital, Office-based physicians, Pharmacy, Other end-users.

Global E Prescribing Market: Recent Developments

  • In March 2022,

Cerner Corporation announced its partnership with Nuance Communications to integrate AI-powered e-prescribing tools into Cerner’s electronic health record (EHR) system. This collaboration aimed to improve the accuracy of prescribing medications, reduce errors, and streamline the prescription process for healthcare providers by utilizing AI-driven insights.

  • In June 2022,

Surescripts launched the CareEvent solution, an advanced feature of its e-prescribing platform. This tool provides real-time clinical updates and alerts for care providers to help manage patient conditions more efficiently and improve the accuracy and timeliness of medication prescribing.

  • In February 2023,

Epic Systems expanded its e-prescribing network by integrating with health systems in several European countries. This move marked the company’s efforts to globalize e-prescribing and digital health solutions, helping healthcare providers improve prescription safety and medication adherence across different healthcare ecosystems.

  • In May 2023,

Rx.Health launched a new digital platform with integrated e-prescribing features designed to help healthcare providers optimize patient medication management. The platform aimed to enhance personalized patient care by offering a seamless, digital-first approach to e-prescribing, including features such as medication tracking, refill alerts, and patient education.

Key Market Players:

Global E Prescribing Market features several key players that dominate the industry, including

  • Allscripts Healthcare, LLC
  • Athenahealth
  • Change Healthcare
  • DrFirst
  • Epic Systems Corporation
  • McKesson Corporation
  • Networking Technology, Inc
  • NXGN Management, LLC
  • Practice Fusion, Inc.
  • Surescripts

Table of Content

CHAPTER 1: EXECUTIVE SUMMARY
1.1. Summary
CHAPTER 2: RESEARCH METHODOLOGY
2.1. Research Process
2.2. Primary Research
2.3. Secondary Research
2.4. Market Size Estimation
2.5. Research Methodology
2.6. Analyst Tools/Models/Techniques
2.6.1. Notations
2.7. Market Scope & Segmentation
2.8. Currency & Pricing Considered
CHAPTER 3: MARKET TRENDS
3.1. Introduction
3.2. Drivers
3.2.1. Technological Advancements
3.2.2. Government Initiatives and Regulations
3.2.3. Increasing Incidence of Chronic Diseases
3.2.4. Driver 4
3.3. Restraints
3.3.1. Integration and Interoperability Issues
3.3.2. Restraint 2
3.3.3. Restraint 3
3.3.4. Restraint 4
3.4. Opportunities
3.4.1. Expansion in Emerging Markets
3.4.2. Advancements in Mobile Health Applications
3.4.3. Focus on Patient Safety and Error Reduction
3.4.4. Opportunity 4
3.5. Challenges
3.5.1. Challenge 1
3.5.2. Challenge 2
3.5.3. Challenge 3
3.5.4. Challenge 4
3.6. Investment Feasibility Analysis
3.7. Latest Trends
CHAPTER 4: MARKET ASSESSMENT
4.1. Porters Five Forces Analysis
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitute
4.1.5. Intensity of Competitive Rivalry
4.2. Value Chain Analysis
4.3. Market Share Analysis
4.4. Impact of Key Regulations on the Market
4.5. SWOT Analysis
4.6. PESTEL Analysis
4.7. Patent Analysis
4.7.1. By COMPONENT
4.7.2. By DELIVERY MODE
4.7.3. By SUBSTANCES
4.7.4. By USAGE
4.8. Roadmap Development
4.9. Market Lineage Outlook
4.9.1. Parent Market Outlook
4.9.2. Ancillary Market Outlook
CHAPTER 5: IMPACT OF RECESSION ON THE MARKET
5.1. Introduction
5.1.1. Short Term Impact
5.1.2. Long Term Impact
CHAPTER 6: GLOBAL E PRESCRIBING MARKET, BY COMPONENT
6.1. Introduction
6.1.1. Market Size & Forecast
6.1.2. Global E PRESCRIBING Market Share, by Component -2023 and 2031 (%)
6.2. SOLUTION
6.2.1. Key market Trends, Growth Factors, and Opportunities
6.2.2. Market Size and Forecast, by Regions
6.3. SERVICES
6.3.1. Key market Trends, Growth Factors, and Opportunities
6.3.2. Market Size and Forecast, by Regions
CHAPTER 7: GLOBAL E PRESCRIBING MARKET, BY DELIVERY MODE
7.1. Introduction
7.1.1. Market Size & Forecast
7.1.2. Global E PRESCRIBING Market Share, DELIVERY MODE -2023 and 2031 (%)
7.2. WEB/CLOUD-BASED
7.2.1. Key market Trends, Growth Factors, and Opportunities
7.2.2. Market Size and Forecast, by Regions
7.3. ON-PREMISES
7.3.1. Key market Trends, Growth Factors, and Opportunities
7.3.2. Market Size and Forecast, by Regions
CHAPTER 8: GLOBAL E PRESCRIBING MARKET, BY SUBSTANCES
8.1. Introduction
8.1.1. Market Size & Forecast
8.1.2. Cloud Storage Market Share, by SUBSTANCES -2023 and 2031 (%)
8.2. CONTROLLED SUBSTANCES
8.2.1. Key market Trends, Growth Factors, and Opportunities
8.2.2. Market Size and Forecast, by Regions
8.3. NON-CONTROLLED SUBSTANCES
8.3.1. Key market Trends, Growth Factors, and Opportunities
8.3.2. Market Size and Forecast, by Regions
CHAPTER 9: GLOBAL E PRESCRIBING MARKET, BY USAGE
9.1. Introduction
9.1.1. Market Size & Forecast
9.1.2. Global E PRESCRIBING Market Share, by USAGE -2023 and 2031 (%)
9.2. HANDHELD
9.2.1. Key market Trends, Growth Factors, and Opportunities
9.2.2. Market Size and Forecast, by Regions
9.3. COMPUTER-BASED DEVICES
9.3.1. Key market Trends, Growth Factors, and Opportunities
9.3.2. Market Size and Forecast, by Regions
CHAPTER 10: NORTH AMERICA MARKET ANALYSIS
10.1. Introduction
10.2. E PRESCRIBING Market by Country
10.3. North America E PRESCRIBING Market by Country, USD Million 2019-2031
10.3.1. Market Size & Forecast, By COMPONENT
10.3.2. Market Size & Forecast, by DELIVERY MODE
10.3.3. Market Size & Forecast, by SUBSTANCES
10.3.4. Market Size & Forecast, by USAGE
10.4. U.S.
10.4.1. Market Size & Forecast, By COMPONENT
10.4.2. Market Size & Forecast, by DELIVERY MODE
10.4.3. Market Size & Forecast, by SUBSTANCES
10.4.4. Market Size & Forecast, by USAGE
10.5. Canada
10.5.1. Market Size & Forecast, By COMPONENT
10.5.2. Market Size & Forecast, by DELIVERY MODE
10.5.3. Market Size & Forecast, by SUBSTANCES
10.5.4. Market Size & Forecast, by USAGE
CHAPTER 11: EUROPE MARKET ANALYSIS
11.1. Introduction
11.2. E PRESCRIBING Market by Country
11.3. Europe E PRESCRIBING Market by Country, USD Million 2019-2031
11.3.1. Market Size & Forecast, By COMPONENT
11.3.2. Market Size & Forecast, by DELIVERY MODE
11.3.3. Market Size & Forecast, by SUBSTANCES
11.3.4. Market Size & Forecast, by USAGE
11.4. Germany
11.4.1. Market Size & Forecast, By COMPONENT
11.4.2. Market Size & Forecast, by DELIVERY MODE
11.4.3. Market Size & Forecast, by SUBSTANCES
11.4.4. Market Size & Forecast, by USAGE
11.5. France
11.5.1. Market Size & Forecast, By COMPONENT
11.5.2. Market Size & Forecast, by DELIVERY MODE
11.5.3. Market Size & Forecast, by SUBSTANCES
11.5.4. Market Size & Forecast, by USAGE
11.6. U.K.
11.6.1. Market Size & Forecast, By COMPONENT
11.6.2. Market Size & Forecast, by DELIVERY MODE
11.6.3. Market Size & Forecast, by SUBSTANCES
11.6.4. Market Size & Forecast, by USAGE
11.7. Italy
11.7.1. Market Size & Forecast, By COMPONENT
11.7.2. Market Size & Forecast, by DELIVERY MODE
11.7.3. Market Size & Forecast, by SUBSTANCES
11.7.4. Market Size & Forecast, by USAGE
11.8. Spain
11.8.1. Market Size & Forecast, By COMPONENT
11.8.2. Market Size & Forecast, by DELIVERY MODE
11.8.3. Market Size & Forecast, by SUBSTANCES
11.8.4. Market Size & Forecast, by USAGE
11.9. Benelux
11.9.1. Market Size & Forecast, By COMPONENT
11.9.2. Market Size & Forecast, by DELIVERY MODE
11.9.3. Market Size & Forecast, by SUBSTANCES
11.9.4. Market Size & Forecast, by USAGE
11.10. Rest of Europe
11.10.1. Market Size & Forecast, By COMPONENT
11.10.2. Market Size & Forecast, by DELIVERY MODE
11.10.3. Market Size & Forecast, by SUBSTANCES
11.10.4. Market Size & Forecast, by USAGE
CHAPTER 12: ASIA-PACIFIC MARKET ANALYSIS
12.1. Introduction
12.2. E PRESCRIBING Market by Country
12.3. Asia Pacific Cloud Storage Market by Country, USD Million 2019-2031
12.3.1. Market Size & Forecast, By COMPONENT
12.3.2. Market Size & Forecast, by DELIVERY MODE
12.3.3. Market Size & Forecast, by SUBSTANCES
12.3.4. Market Size & Forecast, by USAGE
12.4. China
12.4.1. Market Size & Forecast, By COMPONENT
12.4.2. Market Size & Forecast, by DELIVERY MODE
12.4.3. Market Size & Forecast, by SUBSTANCES
12.4.4. Market Size & Forecast, by USAGE
12.5. India
12.5.1. Market Size & Forecast, By COMPONENT
12.5.2. Market Size & Forecast, by DELIVERY MODE
12.5.3. Market Size & Forecast, by SUBSTANCES
12.5.4. Market Size & Forecast, by USAGE
12.6. Japan
12.6.1. Market Size & Forecast, By COMPONENT
12.6.2. Market Size & Forecast, by DELIVERY MODE
12.6.3. Market Size & Forecast, by SUBSTANCES
12.6.4. Market Size & Forecast, by USAGE
12.7. Australia
12.7.1. Market Size & Forecast, By COMPONENT
12.7.2. Market Size & Forecast, by DELIVERY MODE
12.7.3. Market Size & Forecast, by SUBSTANCES
12.7.4. Market Size & Forecast, by USAGE
12.8. South Korea
12.8.1. Market Size & Forecast, By COMPONENT
12.8.2. Market Size & Forecast, by DELIVERY MODE
12.8.3. Market Size & Forecast, by SUBSTANCES
12.8.4. Market Size & Forecast, by USAGE
12.9. Souethest Asia
12.9.1. Market Size & Forecast, By COMPONENT
12.9.2. Market Size & Forecast, by DELIVERY MODE
12.9.3. Market Size & Forecast, by SUBSTANCES
12.9.4. Market Size & Forecast, by USAGE
12.10. Rest of Asia Pacific
12.10.1. Market Size & Forecast, By COMPONENT
12.10.2. Market Size & Forecast, by DELIVERY MODE
12.10.3. Market Size & Forecast, by SUBSTANCES
12.10.4. Market Size & Forecast, by USAGE
CHAPTER 13: LATIN AMERICA AND THE CARIBBEAN MARKET ANALYSIS
13.1. Introduction
13.2. E PRESCRIBING Market by Country
13.3. Latin America E PRESCRIBING Market by Country, USD Million 2019-2031
13.3.1. Market Size & Forecast, By COMPONENT
13.3.2. Market Size & Forecast, by DELIVERY MODE
13.3.3. Market Size & Forecast, by SUBSTANCES
13.3.4. Market Size & Forecast, by USAGE
13.4. Brazil
13.4.1. Market Size & Forecast, By COMPONENT
13.4.2. Market Size & Forecast, by DELIVERY MODE
13.4.3. Market Size & Forecast, by SUBSTANCES
13.4.4. Market Size & Forecast, by USAGE
13.5. Mexico
13.5.1. Market Size & Forecast, By COMPONENT
13.5.2. Market Size & Forecast, by DELIVERY MODE
13.5.3. Market Size & Forecast, by SUBSTANCES
13.5.4. Market Size & Forecast, by USAGE
13.6. Rest of Latin America
13.6.1. Market Size & Forecast, By COMPONENT
13.6.2. Market Size & Forecast, by DELIVERY MODE
13.6.3. Market Size & Forecast, by SUBSTANCES
13.6.4. Market Size & Forecast, by USAGE
CHAPTER 14: THE MIDDLE EAST AND AFRICA MARKET ANALYSIS
14.1. Introduction
14.2. E PRESCRIBING Market by Country
14.3. MEA E PRESCRIBING Market by Country, USD Million 2019-2031
14.3.1. Market Size & Forecast, By COMPONENT
14.3.2. Market Size & Forecast, by DELIVERY MODE
14.3.3. Market Size & Forecast, by SUBSTANCES
14.3.4. Market Size & Forecast, by USAGE
14.4. South Africa
14.4.1. Market Size & Forecast, By COMPONENT
14.4.2. Market Size & Forecast, by DELIVERY MODE
14.4.3. Market Size & Forecast, by SUBSTANCES
14.4.4. Market Size & Forecast, by USAGE
14.5. Saudi Arabia
14.5.1. Market Size & Forecast, By COMPONENT
14.5.2. Market Size & Forecast, by DELIVERY MODE
14.5.3. Market Size & Forecast, by SUBSTANCES
14.5.4. Market Size & Forecast, by USAGE
14.6. UAE
14.6.1. Market Size & Forecast, By COMPONENT
14.6.2. Market Size & Forecast, by DELIVERY MODE
14.6.3. Market Size & Forecast, by SUBSTANCES
14.6.4. Market Size & Forecast, by USAGE
14.7. Rest of MEA
14.7.1. Market Size & Forecast, By COMPONENT
14.7.2. Market Size & Forecast, by DELIVERY MODE
14.7.3. Market Size & Forecast, by SUBSTANCES
14.7.4. Market Size & Forecast, by USAGE
CHAPTER 15: COMPETITIVE LANDSCAPE
15.1. Introduction
15.2. Market Player Positioning, 2022
15.3. Company Evaluation Matrix
15.4. Product Mapping of Top 10 Player
15.5. Market Opportunities and Future Trends
15.6. Competitive Heatmap
15.7. Top Winning Growth Strategies
15.7.1. Major Growth Strategies
15.7.2. Expansion
15.7.3. Merger and Acquisition
15.7.4. Other Developments
CHAPTER 16: COMPANY PROFILES
16.1. ALLSCRIPTS HEALTHCARE, LLC
16.1.1. Company Overview
16.1.2. Key Executives
16.1.3. Financial Overview
16.1.4. Business Componentnalysis
16.1.5. Product Portfolio
16.1.6. Key Strategic Developments
16.2. ATHENAHEALTH
16.3. CHANGE HEALTHCARE
16.4. DRFIRST
16.5. EPIC SYSTEMS CORPORATION
16.6. MCKESSON CORPORATION
16.7. NETWORKING TECHNOLOGY, INC
16.8. NXGN MANAGEMENT, LLC
16.9. PRACTICE FUSION, INC
16.10. SURESCRIPTS
16.11. Others

Tables and Figures

LIST OF TABLES
Table 1. Global E PRESCRIBING Market INDUSTRY SNAPSHOT, 2022-2031
Table 2. Global E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 3. Global E PRESCRIBING Market SOLUTION , BY REGION-2019-2031 (USD MILLION)
Table 4. Global E PRESCRIBING Market SERVICES, BY REGION-2019-2031 (USD MILLION)
Table 5. Global E PRESCRIBING Market SHARE, by DELIVERY MODE SIZE-2019-2031 (USD MILLION)
Table 6. Global E PRESCRIBING Market WEB/CLOUD-BASED, BY REGION-2019-2031 (USD MILLION)
Table 7. Global E PRESCRIBING Market ON-PREMISES, BY REGION-2019-2031 (USD MILLION)
Table 8. Global E PRESCRIBING Market SHARE, by SUBSTANCES -2019-2031 (USD MILLION)
Table 9. Global E PRESCRIBING Market CONTROLLED SUBSTANCES, BY REGION-2019-2031 (USD MILLION)
Table 10. Global E PRESCRIBING Market NON-CONTROLLED SUBSTANCES, BY REGION-2019-2031 (USD MILLION)
Table 11. Global E PRESCRIBING Market SHARE, USAGE -2019-2031 (USD MILLION)
Table 12. Global E PRESCRIBING Market FOR HANDHELD, BY REGION-2019-2031 (USD MILLION)
Table 13. Global E PRESCRIBING Market FOR COMPUTER-BASED DEVICES BY REGION-2019-2031 (USD MILLION)
Table 14. NORTH AMERICA E PRESCRIBING Market BY COUNTRY, USD MILLION 2019-2031
Table 15. NORTH AMERICA E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 16. NORTH AMERICA E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 17. NORTH AMERICA E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 18. NORTH AMERICA E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 19. U.S. E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 20. U.S. E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 21. U.S. E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 22. U.S. E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 23. CANADA E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 24. CANADA E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 25. CANADA E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 26. CANADA E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 27. EUROPE E PRESCRIBING Market BY COUNTRY, USD MILLION 2019-2031
Table 28. EUROPE E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 29. EUROPE E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 30. EUROPE E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 31. EUROPE E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 32. GERMANY E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 33. GERMANY E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 34. GERMANY E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 35. GERMANY E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 36. FRANCE E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 37. FRANCE E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 38. FRANCE E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 39. FRANCE E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 40. UK E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 41. UK E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 42. UK E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 43. UK E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 44. ITALY E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 45. ITALY E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 46. ITALY E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 47. ITALY E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 48. SPAIN E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 49. SPAIN E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 50. SPAIN E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 51. SPAIN E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 52. BENELUX E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 53. BENELUX E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 54. BENELUX E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 55. BENELUX E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 56. REST OF EUROPE E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 57. REST OF EUROPE E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 58. REST OF EUROPE E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 59. REST OF EUROPE E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 60. ASIA PACIFIC E PRESCRIBING Market BY COUNTRY, USD MILLION 2019-2031
Table 61. ASIA PACIFIC E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 62. ASIA PACIFIC E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 63. ASIA PACIFIC E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 64. ASIA PACIFIC E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 65. CHINA E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 66. CHINA E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 67. CHINA E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 68. CHINA E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 69. INDIA E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 70. INDIA E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 71. INDIA E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 72. INDIA E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 73. JAPAN E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 74. JAPAN E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 75. JAPAN E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 76. JAPAN E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 77. AUSTRALIA E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 78. AUSTRALIA E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 79. AUSTRALIA E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 80. AUSTRALIA E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 81. SOUTH KOREA E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 82. SOUTH KOREA E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 83. SOUTH KOREA E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 84. SOUTH KOREA E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 85. SOUETHEST ASIA E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 86. SOUETHEST ASIA E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 87. SOUETHEST ASIA E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 88. SOUETHEST ASIA E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 89. REST OF ASIA PACIFIC E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 90. REST OF ASIA PACIFIC E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 91. REST OF ASIA PACIFIC E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 92. REST OF ASIA PACIFIC E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 93. LATIN AMERICA E PRESCRIBING Market BY COUNTRY, USD MILLION 2019-2031
Table 94. LATIN AMERICA E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 95. LATIN AMERICA E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 96. LATIN AMERICA E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 97. LATIN AMERICA E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 98. BRAZIL E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 99. BRAZIL E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 100. BRAZIL E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 101. BRAZIL E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 102. MEXICO E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 103. MEXICO E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 104. MEXICO E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 105. MEXICO E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 106. REST OF LATIN AMERICA E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 107. REST OF LATIN AMERICA E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 108. REST OF LATIN AMERICA E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 109. REST OF LATIN AMERICA E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 110. MEA E PRESCRIBING Market BY COUNTRY, USD MILLION 2019-2031
Table 111. MEA E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 112. MEA E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 113. MEA E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 114. MEA E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 115. SOUTH AFRICA E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 116. SOUTH AFRICA E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 117. SOUTH AFRICA E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 118. SOUTH AFRICA E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 119. SAUDI ARABIA E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 120. SAUDI ARABIA E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 121. SAUDI ARABIA E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 122. SAUDI ARABIA E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 123. UAE E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 124. UAE E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 125. UAE E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 126. UAE E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 127. REST OF MEA E PRESCRIBING Market SHARE, by COMPONENT -2019-2031 (USD MILLION)
Table 128. REST OF MEA E PRESCRIBING Market SHARE, by DELIVERY MODE -2019-2031 (USD MILLION)
Table 129. REST OF MEA E PRESCRIBING Market SHARE, by SUBSTANCES – 2019-2031 (USD MILLION)
Table 130. REST OF MEA E PRESCRIBING Market SHARE, by USAGE -2019-2031 (USD MILLION)
Table 131. KEY EXPANSIONS (2019-2022)
Table 132. KEY MERGERS AND ACQUISITION (2019-2022)
Table 133. OTHER KEY DEVELOPMENTS (2019-2022)

LIST OF FIGURES
Figure 1. REGIONAL ANALYSIS (2022 & 2031)
Figure 2. RESEARCH PROCESS
Figure 3. ANALYSIS FRAMEWORK
Figure 4. IMPACT OF KEY REGULATION ON THE MARKET
Figure 5. SWOT ANALYSIS
Figure 6. Global E PRESCRIBING Market SHARE, by COMPONENT -2023 & 2031 (USD MILLION)
Figure 7. Global E PRESCRIBING Market , SOLUTION -2019-2031 (USD MILLION)
Figure 8. Global E PRESCRIBING Market , SERVICES -2019-2031 (USD MILLION)
Figure 9. Global E PRESCRIBING Market SHARE, by DELIVERY MODE -2023 & 2031 (USD MILLION)
Figure 10. Global E PRESCRIBING Market , WEB/CLOUD-BASED -2019-2031 (USD MILLION)
Figure 11. Global E PRESCRIBING Market , ON-PREMISES -2019-2031 (USD MILLION)
Figure 12. Global E PRESCRIBING Market SHARE, by SUBSTANCES -2023 & 2031 (USD MILLION)
Figure 13. Global E PRESCRIBING Market , CONTROLLED SUBSTANCES -2019-2031 (USD MILLION)
Figure 14. Global E PRESCRIBING Market , NON-CONTROLLED SUBSTANCES -2019-2031 (USD MILLION)
Figure 15. Global E PRESCRIBING Market SHARE, by USAGE -2023 & 2031 (USD MILLION)
Figure 16. Global E PRESCRIBING Market , HANDHELD -2019-2031 (USD MILLION)
Figure 17. Global E PRESCRIBING Market , COMPUTER-BASED DEVICES -2019-2031 (USD MILLION)
Figure 18. MARKET PLAYER POSITIONING, 2022
Figure 19. COMPANY EVALUATION MATRIX
Figure 20. PRODUCT MAPPING OF TOP 10 PLAYERS
Figure 21. COMPETITIVE HEATMAP OF KEY PLAYERS

Frequently Asked Questions

  • Who are the major players in the e-prescribing market?

    Key companies include Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions, Surescripts, and NextGen Healthcare, Inc. These companies are leading the development and implementation of e-prescribing technologies.
  • Which regions are experiencing the fastest growth?

    The Asia-Pacific region is expected to grow at the highest CAGR over the forecast period (2024-2029), while North America currently holds the largest market share due to extensive government support and healthcare infrastructure.
  • What are the challenges facing the market?

    High Implementation Costs: The initial investment and ongoing maintenance costs of e-prescribing systems can be prohibitive, particularly for smaller healthcare providers. Workflow Disruptions: Transitioning to e-prescribing may disrupt existing workflows, causing resistance among healthcare professionals. Security Concerns: Ensuring the security of electronic prescriptions and patient data is a significant concern that needs to be addressed for wider adoption.